{"id":17753,"date":"2023-08-21T15:19:18","date_gmt":"2023-08-21T13:19:18","guid":{"rendered":"https:\/\/www.curus.se\/nyheter\/curus-carries-out-new-share-issue\/"},"modified":"2024-08-20T15:28:23","modified_gmt":"2024-08-20T13:28:23","slug":"curus-carries-out-new-share-issue","status":"publish","type":"post","link":"https:\/\/www.curus.se\/en\/nyheter\/curus-carries-out-new-share-issue\/","title":{"rendered":"Curus carries out new share issue"},"content":{"rendered":"

Healthtech-focused investment company Curus carries out a new share issue to support the company’s growth ambitions and enable further investments.<\/strong> Curus was founded in 2021 by Johan Bloom and has since raised capital from Alfv\u00e9n & Didrikson, Stefan Bengtsson, e-health entrepreneur Alexander Stendahl, Christian Dahlberg and business angel Lars Lindgren, among others.
\nThe new share issue, which was led by Alfv\u00e9n & Didrikson, provides the company with an additional SEK 43 million.
\nIn connection with this, Curus welcomes new investors, including Fredrik Str\u00f6mholm (founder of Impilo), Klas Tikkanen (COO and partner at Nordic Capital), Johan Dettel (former partner at EQT) and the Versteegh Group, owner of, among other things, Apotekstj\u00e4nst.
\n“We are very pleased to welcome several new investors who strengthen Curus with additional experience, expertise and contact networks. This capital raising is in line with our growth ambitions where we see interesting opportunities in the market that we want to have the chance to act on. With renewed confidence from existing investors, we now have the opportunity to continue to invest and support several companies in health and care with a focus on the digital future.”, <\/em>says Erik Olsson Nyr\u00e9n, Investment Manager at Curus.
\nThe second largest shareholder after founder Johan Bloom is Alfv\u00e9n & Didrikson, which is an active and long-term partner to entrepreneurs and companies with international growth ambitions.
\n“Curus has built a great platform for further expansion and we are grateful to be part of and support the team”, <\/em>says Ken Liebkind, Partner at Alfv\u00e9n & Didrikson.<\/p>\n

For more information <\/strong>Johan Bloom, CEO, Curus,
\njohan.bloom@curus.se,<\/a> 073-364 84 90 Erik Olsson Nyr\u00e9n, Investment Manager, Curus erik.olsson.nyren@curus.se,<\/a> 070-837 73 54 Ken Liebkind, Partner, Alfv\u00e9n & Didrikson ken@alfvendidrikson.com<\/a>\u00a0About Curus<\/strong> Curus is an investment company that invests in the Nordic region with a particular focus on digital health and healthcare. Curus has the opportunity to make both minority and majority investments and can contribute both capital, industry experience and networks as well as marketing to our portfolio companies. Curus has investments in 5 majority-owned companies and a minority stake in 22 growth companies. For more information, see www.curus.se.<\/a> About Alfv\u00e9n & Didrikson<\/strong> Alfv\u00e9n & Didrikson is an active and long-term partner to entrepreneurs and companies with international growth ambitions.
\nSince its inception in 2010, the team at Alfv\u00e9n & Didrikson has invested in fast-growing Northern European companies such as Trustly, Quinyx, Acast, Mentimeter, Sympa, Paligo and Kognity.
\nFor more information, see www.alfvendidrikson.com.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Healthtech-focused investment company Curus carries out a new share issue to support the company’s growth ambitions and enable further investments. Curus was founded in 2021 by Johan Bloom and has since raised capital from Alfv\u00e9n & Didrikson, Stefan Bengtsson, e-health entrepreneur Alexander Stendahl, Christian Dahlberg and business angel Lars Lindgren, among others. The new share […]<\/p>\n","protected":false},"author":24,"featured_media":17702,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[306,303,304],"tags":[],"class_list":["post-17753","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-investment-en-2","category-nyheter-en","category-pressmeddelande-en"],"_links":{"self":[{"href":"https:\/\/www.curus.se\/en\/wp-json\/wp\/v2\/posts\/17753","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.curus.se\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.curus.se\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.curus.se\/en\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/www.curus.se\/en\/wp-json\/wp\/v2\/comments?post=17753"}],"version-history":[{"count":1,"href":"https:\/\/www.curus.se\/en\/wp-json\/wp\/v2\/posts\/17753\/revisions"}],"predecessor-version":[{"id":17794,"href":"https:\/\/www.curus.se\/en\/wp-json\/wp\/v2\/posts\/17753\/revisions\/17794"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.curus.se\/en\/wp-json\/wp\/v2\/media\/17702"}],"wp:attachment":[{"href":"https:\/\/www.curus.se\/en\/wp-json\/wp\/v2\/media?parent=17753"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.curus.se\/en\/wp-json\/wp\/v2\/categories?post=17753"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.curus.se\/en\/wp-json\/wp\/v2\/tags?post=17753"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}